Detalles de la búsqueda
1.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728217
2.
Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE).
Br J Haematol
; 189(2): 303-312, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32012231
3.
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas.
Ann Hematol
; 99(1): 83-91, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807859
4.
Treatment with intravenous busulfan, melphalan, and etoposide followed by autologous stem cell transplantation in patients with non-Hodgkin's lymphoma: a multicenter study from the consortium for improving survival of lymphoma.
Transpl Int
; 33(10): 1211-1219, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32479690
5.
Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials.
Acta Haematol
; 143(3): 232-243, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31390612
6.
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic Index.
Ann Hematol
; 98(12): 2739-2748, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31712879
7.
Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150).
Biol Blood Marrow Transplant
; 24(5): 923-929, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29339269
8.
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2482-2483, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221329
9.
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2274-2284, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056546
10.
The Derived Neutrophil-to-Lymphocyte Ratio Is an Independent Prognostic Factor in Transplantation Ineligible Patients with Multiple Myeloma.
Acta Haematol
; 140(3): 146-156, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30253397
11.
Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study.
Haematologica
; 101(6): 717-23, 2016 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888022
12.
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective study.
Ann Hematol
; 95(4): 603-11, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26754633
13.
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual Disease.
Acta Haematol
; 135(3): 133-9, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26535871
14.
Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
Biol Blood Marrow Transplant
; 21(9): 1597-604, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25963920
15.
Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation.
Ann Hematol
; 94(4): 617-25, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25465233
16.
Weekly rituximab consolidation following four cycles of R-CHOP induction chemotherapy in very elderly patients with diffuse large B-cell lymphoma: Consortium for improving survival of lymphoma study (CISL).
Eur J Haematol
; 94(6): 504-10, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25288018
17.
Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors.
Haematologica
; 99(7): 1191-6, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24705186
18.
Concurrent chemoradiotherapy followed by L-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study.
Ann Hematol
; 93(11): 1895-901, 2014 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-24947798
19.
Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea-experience from 110 patients.
Ann Hematol
; 93(1): 113-21, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24026427
20.
Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
Ann Hematol
; 93(8): 1353-61, 2014 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-24671365